Foghorn Therapeutics Inc. (FHTX) Operating cash flow 2019–2025
Foghorn Therapeutics Inc. (FHTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$86.1MFY2025 · since FY2019: -$46.3M → -$86.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.1M | +14.2% |
| FY2024 | -$100.4M | +15.0% |
| FY2023 | -$118.1M | -161.0% |
| FY2022 | $193.6M | +485.3% |
| FY2021 | -$50.3M | -60.6% |
| FY2020 | -$31.3M | +32.5% |
| FY2019 | -$46.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice